Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke-evaluating the impact of therapeutic time points on prognostic outcomes.
Angiogenesis
Endothelial progenitor cells
Ischemic stroke
Neurological function
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
05 06 2020
05 06 2020
Historique:
received:
07
02
2020
accepted:
20
05
2020
revised:
06
05
2020
entrez:
7
6
2020
pubmed:
7
6
2020
medline:
22
6
2021
Statut:
epublish
Résumé
This study tested the optimal time point for left intra-carotid arterial (LICA) administration of circulatory-derived autologous endothelial progenitor cells (EPCs) for improving the outcome in rat after acute ischemic stroke (IS). Adult male SD rats (n = 70) were equally categorized into group 1 (sham-operated control), group 2 (IS), group 3 (IS+EPCs/1.2 × 10 Early EPC administration provided better benefits on improving functional/image/molecular-cellular outcomes after acute IS in rat.
Sections du résumé
BACKGROUND
This study tested the optimal time point for left intra-carotid arterial (LICA) administration of circulatory-derived autologous endothelial progenitor cells (EPCs) for improving the outcome in rat after acute ischemic stroke (IS).
METHODS AND RESULTS
Adult male SD rats (n = 70) were equally categorized into group 1 (sham-operated control), group 2 (IS), group 3 (IS+EPCs/1.2 × 10
CONCLUSION
Early EPC administration provided better benefits on improving functional/image/molecular-cellular outcomes after acute IS in rat.
Identifiants
pubmed: 32503671
doi: 10.1186/s13287-020-01739-y
pii: 10.1186/s13287-020-01739-y
pmc: PMC7275327
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
219Références
N Engl J Med. 2001 Oct 11;345(15):1084-90
pubmed: 11596587
Stroke. 2002 Dec;33(12):2916-22
pubmed: 12468791
Stroke. 2000 Jun;31(6):1240-9
pubmed: 10835439
Stroke. 2008 Jan;39(1):69-74
pubmed: 18063830
Crit Care. 2011;15(1):R40
pubmed: 21269484
JAMA. 1991 Dec 18;266(23):3289-94
pubmed: 1960828
N Engl J Med. 1998 Nov 12;339(20):1415-25
pubmed: 9811916
Ann Neurol. 2019 Jul;86(1):5-16
pubmed: 31020699
J Cereb Blood Flow Metab. 2014 Jan;34(1):e1-9
pubmed: 24169850
Am Heart J. 2011 Oct;162(4):671-7
pubmed: 21982659
Exp Transl Stroke Med. 2012 Aug 24;4(1):17
pubmed: 22920434
Int J Cardiol. 2015 Dec 15;201:668-83
pubmed: 26363631
Circ J. 2008 Aug;72(8):1336-45
pubmed: 18654023
Eur Heart J. 2010 Mar;31(6):691-702
pubmed: 20022872
Cerebrovasc Dis. 2005;20(2):120-8
pubmed: 16006760
Crit Care Med. 2009 Apr;37(4):1197-205
pubmed: 19242323
Stroke. 2001 Nov;32(11):2559-66
pubmed: 11692017
Biomed Pharmacother. 2019 Aug;116:108954
pubmed: 31108352
J Clin Invest. 2004 Aug;114(3):330-8
pubmed: 15286799
Brain Res. 2011 Mar 24;1381:237-42
pubmed: 21256117
Cell Transplant. 2012;21(6):1199-211
pubmed: 22182968
Stem Cell Res Ther. 2015 Jan 27;6:11
pubmed: 25971703
JAMA. 2000 Mar 15;283(11):1429-36
pubmed: 10732932
Oncotarget. 2016 Nov 15;7(46):74537-74556
pubmed: 27793019
Int J Cardiol. 2011 Jul 15;150(2):156-68
pubmed: 20466442
Stroke. 1991 Jun;22(6):711-20
pubmed: 2057968
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
N Engl J Med. 1977 Feb 17;296(7):358-62
pubmed: 834199
Am J Transl Res. 2018 Sep 15;10(9):2975-2989
pubmed: 30323884
Biomaterials. 2019 Sep;214:119227
pubmed: 31174067
Stroke. 1996 Oct;27(10):1817-20
pubmed: 8841337
Neurology. 2000 Feb 8;54(3):660-6
pubmed: 10680800
Behav Brain Res. 2018 Oct 15;352:161-171
pubmed: 28760700